Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Annals of Hematology|July 1, 2008
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)Carsten Zwick, Josef Birkmann, Norma Peter, et al.Oncogene|May 29, 2002
A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicingOzlem Türeci, Ugur Sahin, Michael Koslowski, et al.Blood|December 4, 2013
Suboptimal dosing of rituximab in male and female patients with DLBCLMichael Pfreundschuh, Carsten Müller, Samira Zeynalova, et al.Springerplus|January 24, 2014
Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHLKarin Hohloch, Carsten Zwick, Marita Ziepert, et al.International Journal of Cancer|January 25, 2006
Serological immune response to cancer testis antigens in patients with pancreatic cancerAndreas Wadle, Boris Kubuschok, Jochen Imig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphomaGerhard Held, Niels Murawski, Marita Ziepert, et al.International Journal of Cancer|January 21, 2014
Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MMCarsten Zwick, Gerhard Held, Michaela Auth, et al.European Journal of Immunology|June 15, 2007
MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processingGerhard Held, Andreas Wadle, Nina Dauth, et al.Blood|June 19, 2014
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomasNiels Murawski, Gerhard Held, Marita Ziepert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvementGerhard Held, Samira Zeynalova, Niels Murawski, et al.Pageof 3